Share
News
-
22 December 2009 /Product information
Warning against the potency-enhancing product Rock Hard Weekend
The Danish Medicines Agency strongly warns against using the potency-enhancing product Rock Hard Weekend after the FDA (U.S. Food and Drug Administration) has notified the Danish Medicines Agency that Rock Hard Weekend contains an undeclared active substance and that the product has been exported from the USA to Denmark.
-
09 December 2009 /Product information
Warning against the weight-loss product Super Slim
The Danish Medicines Agency strongly warns against using the weight-loss product Super Slim. We do so based on a warning from the Swedish Medical Products Agency against Super Slim, which is sold on the internet.
-
26 August 2009 /Product information
Danish Medicines Agency hosts conference on biosimulation
Christiansborg Palace in Copenhagen sets the scene for a three-day conference where a group of leading scientists meet to take stock of recent years' progress of using computer modelling to develop medicines, an area also known as biosimulation.
-
11 May 2009 /Product information
Extended use of Tamiflu®
The European Medicines Agency, EMEA, has reassessed the use of Tamiflu® in pregnant women and infants who are ill with influenza A(H1N1).
-
07 May 2009 /Product information
Warning on Hydroxycut pills
Stop using Hydroxycut pills, powder and capsules and talk to your doctor about possible side effects or symptoms of liver damage (jaundice, darkening of urine, nausea, vomiting, light-coloured stools, excessive fatigue, stomach or abdominal pain, itching and loss of appetite).
-
04 May 2009 /Product information
Alli® (orlistat) – over-the-counter weight-loss product
From today, pharmacies across Denmark will be offering the weight-loss product Alli®. Alli® contains the active ingredient orlistat, which has been authorised in Denmark and other EU countries since 1998 as a prescription-only weight-loss product.
-
03 April 2009 /Product information
Withdrawal of the NES-Spacer® from AstraZeneca A/S
AstraZeneca has identified a problem with the NES-Spacer®, which is an inhalation device to be used together with asthma medicine. If a patient assembles the NES-Spacer® incorrectly, the patient cannot inhale the medicine, and the simultaneous use of a face mask prevents the patient from breathing.
-
13 January 2009 /Product information
Scabies medicine on its way to Denmark
The many cases of scabies all over Denmark has led to a lack of the medicine, Nix, which is authorised for scabies treatment in Denmark. In cooperation with the Assocation of Danish Pharmacies and the Danish Medicines Agency, the importer has come up with a solution which will ensure relief this week.
